Mary Fidler to Tumor Microenvironment
This is a "connection" page, showing publications Mary Fidler has written about Tumor Microenvironment.
Connection Strength
0.091
-
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial. Clin Cancer Res. 2022 05 13; 28(10):2020-2029.
Score: 0.049
-
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer. Proc Natl Acad Sci U S A. 2020 01 14; 117(2):1119-1128.
Score: 0.042